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	 Missing	 	 Missing	 	
Mean	Age	(SD)	 81.1	(4.78)	 0	 81.9	(5.07)	 0	 <0.001	
Sex	(male)	 1161	(57.3%)	 0	 297	(53.3%)	 0	 0.10	
Race	(non-white)	 204	(10.0%)	 29	(1.4%)	 46	(8.2%)	 15	(2.7%)	 0.23	
Education	≤	12	years	 1127	(55.6%)	 15	(0.7%)	 326	(58.5%)	 7	(1.2%)	 0.17	
SF12	Physical	Component	Score	 42.4	(9.96)	 8	(0.4%)	 39.9	(9.69)	 1	(0.2%)	 <0.001	
SF12	Mental	Component	Score	 53.4	(9.29)	 7	(0.4%)	 51.4	(10.59)	 1	(0.2%)	 <0.001	
Mean	Charlson	Score	(SD)	 3.29	(2.48)	 1	(0%)	 3.68	(2.68)	 1	(0.2%)	 0.002	
Mean	Length	of	Stay	(SD)	 5.44	(4.61)	 0	 6.31	(5.90)	 0	 0.001	
Mean	Social	Support	Score	(SD)	 21.9	(4.22)	 38	(1.9%)	 21.10	(4.96)	 11	(2.0%)	 0.001	
Live	alone	 732	(36.1%)	 2	(0.1%)	 224	(40.2%)	 0	 0.08	







53	(9.5%)	 0.48	40-50%	 384	(18.9%)	 120	(21.5%)	30-40%	 240	(11.8%)	 67	(12.0%)	
<30%	 132	(6.5%)	 32	(5.8%)	
PCI	performed	 1229	(60.6%)	 0	 329	(59.1%)	 0	 0.50	
CABG	performed	 257	(12.7%)	 0	 65	(11.7%)	 0	 0.52	
Polypharmacy	 1251	(61.7%)	 1	(0.1%)	 356	(63.9%)	 0	 0.35	
Bleeding	complication	 504	(24.9%)	 0	 147	(26.4%)	 0	 0.46	




(70.3%)	 7	(0.4%)	 345	(61.9%)	 0	 <0.001	
Needs	assistance	bathing	 103	(5.1%)	 0	 53	(9.5%)	 0	 <0.001	
Needs	assistance	dressing	 102	(5.0%)	 0	 47	(8.4%)	 0	 0.002	
Needs	assistance	rising	from	chair	 89	(4.39%)	 3	(0.2%)	 38	(6.8%)	 0	 0.019	
















Hearing	impairment	 1068	(52.7%)	 1	(0.1%)	 298	(53.5%)	 0	 <0.001	
Visual	impairment	 670	(33.1%)	 1	(0.1%)	 250	(44.9%)	 0	 <0.001	
Cognitive	impairment	 267	(13.2%)	 30	(1.5%)	 106	(19.0%)	 11	(2.0%)	 <0.001	
Unintentional	weight	loss	 377	(18.6%)	 7	(0.4%)	 137	(24.6%)	 4	(0.7%)	 0.001	
>=	Two	falls	in	past	year	 281	(13.9%)	 4	(0.2%)	 200	(35.9%)	 2	(0.36%)	 <0.001	






6	(1.1%)	 0.003	About	as	active	 640	(31.6%)	 189	(33.9%)	
Less	active	 271	(13.4%)	 100	(18.0%)	
PHQ	screen	positive	 239	(11.8%)	 60	(3.0%)	 98	(17.6%)	 14	(2.5%)	 <0.001	


































	 Missing	 	 Missing	 	
Mean	age	(SD)	 81.47	(4.99)	 0	 82.81	(5.23)	 0	 <0.001	
Sex	(male)	 1573	(55.9%)	 0	 98	(51.0%)	 0	 0.19	
Race	(non-white)	 300	(10.6%)	 44	(1.6%)	 17	(8.85%)	 4	(2.1%)	 0.44	











Mean	Charlson	Score	(SD)	 3.52	(2.60)	 2	(0.1%)	 4.08	(2.72)	 0	 0.004	
Mean	length	of	Stay	(SD)	 5.86	(5.32)	 0	 7.01	(5.12)	 0	 0.004	
Mean	Social	Support	Score	(SD)	 21.62	(4.44)	 70	(0.3%)	 20.85	(4.93)	 1	(0.1%)	 0.038	
Live	alone	 1053	(37.4%)	 2	(0.1%)	 91	(47.4%)	 0	 0.006	








PCI	performed	 1628	(57.9%)	 0	 101	(52.6%)	 0	 0.15	
CABG	performed	 338	(12.0%)	 0	 16	(8.3%)	 0	 0.13	
Polypharmacy	 1727	(61.4%)	 1	(0%)	 132	(68.8%)	 0	 0.042	
Bleeding	complication	 726	(25.8%)	 2	(0.1%)	 47	(24.5%)	 0	 0.69	
Acute	kidney	injury	 635	(22.6%)	 2	(0.1%)	 57	(29.7%)	 0	 0.024	
Able	to	walk	¼	mi.	one	month	
before	admission	
1868	(66.4%)	 9	(0.3%)	 113	(58.9%)	 0	 0.028	
Needs	assistance	bathing	 205	(7.3%)	 1	(0%)	 29	(15.1%)	 0	 <0.001	
Needs	assistance	dressing	 195	(6.9%)	 1	(0%)	 21	(10.9%)	 0	 0.038	
Needs	assistance	rising	from	
chair	
164	(5.8%)	 4	(0.1%)	 18	(9.4%)	 0	 0.047	
Needs	assistance	walking	
around	














Hearing	impairment	 1511	(53.7%)	 2	(0.1%)	 101	(52.6%)	 0	 0.76	
Visual	impairment	 1027	(36.5%)	 3	(0.1%)	 87	(45.3%)	 0	 0.015	
Cognitive	impairment	 466	(16.6%)	 46	(1.6%)	 40	(20.8	 3	(1.6%)	 0.13	
Unintentional	weight	loss	 621	(22.1%)	 17	(0.6%)	 50	(26.0%)	 0	 0.22	
2	or	more	falls	in	past	year	 530	(18.8%)	 12	(0.4%)	 63	(32.8%)	 0	 <0.001	




More	active	 1445	(51.35%)	 24	(0.9%)	 89	(46.35%)	 1	(0.5%)	 0.38	
About	as	active	 903	(32.09%)	 69	(35.94%)	
Less	active	 442	(15.71%)	 33	(17.19%)	
PHQ	screen	positive	 382	(13.6%)	 93	(3.3%)	 40	(20.8%)	 6	(3.1%)	 0.005	
























































































































































































































































































































































































































































































	 Missing	 	 Missing	 	
Mean	age	(SD)	 81.63	(5.02)	 0	 80.51	(4.41)	 0	 <0.001	
Sex	(male)	 768	(53.2%)	 0	 582	(61.7%)	 0	 <0.001	
Race	(non-white)	 159	(11.0%)	 27	(1.8%)	 62	(6.6%)	 14	(1.5%)	 <0.001	
Education	≤	12	years	 865	(59.9%)	 17	(1.2%)	 467	(49.5%)	 3	(0.3%)	 <0.001	
Mean	Charlson	Score	(SD)	 3.47	(2.54)	 2	(0%)	 3.11(2.44)	 0	 <0.001	
Mean	length	of	Stay,	days	(SD)	 5.51	(4.72)	 0	 5.64	(5.02)	 0	 0.55	
Mean	Social	Support	Score	(SD)	 21.66	(4.44)	 32	(2.2%)	 21.95	(4.15)	 15	(1.6%)	 0.11	
Live	alone	 568	(39.3%)	 1	(0.1%)	 295	(31.3%)	 0	 <0.001	
MI	
diagnosis	














cost	 133	(9.2%)	 11	(0.8%)	 77	(8.2%)	 3	(0.3%)	 0.36	
PCI	performed	 824	(5.0%)	 0	 630	(66.8%)	 0	 <0.001	














Hearing	impairment	 738	(51.1%)	 0	 515	(54.1%)	 1	(0.1%)	 0.09	
Visual	impairment	 540	(37.4%)	 0	 301	(31.9%)	 1	(0.1%)	 0.007	
Cognitive	impairment	 254	(17.6%)	 19	(1.3%)	 78	(8.8%)	 18	(1.9%)	 <0.001	
Unintentional	weight	loss	 306	(21.2%)	 7	(0.5%)	 164	(17.4%)	 3	(0.3%)	 0.021	
>=	Two	falls	in	past	year	 292	(20.2%)	 4	(0.3%)	 153	(16.2%)	 2	(0.2%)	 0.014	
Able	to	walk	¼	mile	one	month	






4	(0.4%)	 0.018	About	as	active	 460	(31.9%)	 300	(31.8%)	
Less	active	 226	(15.7%)	 111	(11.8%)	
PHQ	screen	positive	 207	(14.3%)	 44	(3.0%)	 103	(10.9%)	 23	(2.4%)	 0.013	
Problematic	alcohol	use	 75	(5.2%)	 12	(0.8%)	 058	(6.2%)	 4	(0.4%)	 0.33	
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Cardiac Rehabilitation in Older Persons with Cardiovascular Disease
David W. Goldstein1 & Daniel E. Forman2,3
# Springer Science+Business Media, LLC, part of Springer Nature 2018
Abstract
Purpose of Review Despite widespread recommendations, cardiac rehabilitation (CR) is not well utilized in older adults. This
review explores the valuable benefits of CR in geriatric patients as well as strategies to improve utilization.
Recent Findings Eligibility for CR has long included coronary heart disease and has recently expanded to include heart failure,
valvular disease, and peripheral artery disease, all which particularly impact older adults. New research has demonstrated unique
functional and geriatric-specific benefits in older adults who participate in CR.
Summary Though few studies have specifically focused on geriatric populations, these patients have similar benefits to CR in
various types of cardiovascular disease in respect to improved morbidity, rehospitalization, and mortality. Furthermore, older
adults participating in CR commonly derive unique benefits in respect to frailty, mood, and functional status. Nonetheless,
utilization rates are low in the general population, and even lower in older adults. Increasing use of home-based programs
may help increase utilization and benefits among older CR candidates.
Keywords Cardiac rehabilitation . Geriatrics . Cardiovascular disease . Coronary heart disease
Introduction
Cardiac rehabilitation (CR) is a multimodal intervention
consisting of exercise therapy along with risk factor modifica-
tion, education, and psychosocial support. While CR has been
a standard part of cardiovascular management since the 1990s,
its application is at a critical crossroads. Initially designed as a
form of post-acute myocardial infarction (AMI) exercise train-
ing for middle-aged men in outpatient hospital-based pro-
grams, this model of CR has been typically expensive to run
and poorly reimbursed. Moreover, its perceived value has
been additionally eroded by advances in revascularization
and medically stabilizing therapies that are often interpreted
as much more impactful than exercise and lifestyle modifica-
tion. However, the perceived utility of CR has simultaneously
expanded with greater insights about the value of exercise and
wellness behaviors, new indications (e.g., valvular heart dis-
ease, heart failure [HF]), greater application to women, and
greater outreach to a full spectrum of ages. Furthermore, CR
has evolved into a much more extensive intervention than the
exercise therapy that was offered in its inception. Exercise
training is still emphasized, but CR also now incorporates
education, risk factor modification, and counseling. The goals
have evolved to include greater emphasis on healthy lifestyle
patterns, moderating symptoms, increasing exercise tolerance,
and optimizing outpatient management of CVD, including
medication review, and clarifying goals of care. Furthermore,
while most CR is still delivered in the outpatient site-based
(hospital or office) settings, it is also now increasingly available
as a home-based model.
The use of CR in the geriatric population has become a
particularly topical consideration. The population of older
adults is growing rapidly, and aging physiology is fundamen-
tally conducive to development of CVD. The relative benefits
of CR in this older vulnerable population are particularly im-
portant, particularly in respect to achieving functional and
qualitative gains that are typically jeopardized by high inci-
dence of disease and disease events.
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Indications for Cardiac Rehabilitation in Older
Adults
Coronary Heart Disease
From its advent, CR was primarily focused on patients with
coronary heart disease (CHD)—first those who were recover-
ing from AMI, and later those who had been surgically
revascularized. In the early days of CR, the patients referred
were typically younger males, but as life expectancy has in-
creased, the population with CHD has increasingly become
older and more female. These older adults face worse progno-
ses and face more severe disability and functional impairment
than their younger counterparts.
While randomized controlled trials have not definitively
shown a mortality benefit of CR for CHD, there have been
many meta-analyses and elegant propensity analyses. The most
recent Cochrane review on CR for CHD demonstrated a signif-
icant reduction in cardiovascular mortality and all-cause read-
mission in a meta-analysis of 63 studies [1]. The studies con-
tributing to this review were performed in patients of all ages,
and so the specific benefits in the geriatric population are still an
open research question. While not directly comparing older to
younger patients, a propensity study by Suaya in over 600,000
Medicare beneficiaries also showed a significant mortality ben-
efit similar to other studies of younger cohorts [2•].
Heart Failure
Heart failure is a disease that primarily impacts older adults.
Heart failure with reduced ejection fraction (HFrEF) and pre-
served ejection fraction (HFpEF) both occur at markedly
higher rates in older adults than in their younger counterparts
[3–5]. It is a disease that can dramatically impact functional
decline and cause profound disability, especially in older pa-
tients that may otherwise be frail or have comorbid conditions.
Heart failure is a more recently approved indication for CR
[6] and data from trials has shown promising benefit, though
much of the evidence is limited. The most robust study of CR
in patients with HF was the Heart Failure: A Controlled Trial
Investigating Outcomes in exercise training (HF-ACTION)
study. This study of 2331 adults (median age 59, 28%women)
with systolic HF (23% with NYHA class III or IV) showed
significant improvements of mortality or hospitalization
(RR = 0.89 [0.81–0.99]) after adjusting for comorbidities [7].
Within this study, patients aged over 70 years saw no signif-
icant decrease in all-cause mortality or all-cause hospitaliza-
tion, though this was not adjusted for comorbidities in the
same way as the primary analysis.
The most recent Cochrane review [8] on CR for HF also
showed a non-significant reduction in mortality (RR = 0.88
[0.75–1.02]) and a statistically significant reduction in hospi-
talizations (0.75 [0.62–0.92]) among studies with > 1 year of
follow-up. Meta-regression analysis showed that these bene-
fits were independent of age, but no studies included were
dedicated to the geriatric population. A small randomized con-
trolled trial focusing on older adults with HF found a signifi-
cant increase in functional status and health-related quality of
life [9]. The body of evidence around CR’s benefit in HF is
slightly more equivocal, and less proven in the geriatric pop-
ulation, but overall promising.
Valve Repair
Adults recovering from aortic valve replacement are recently
eligible for CR. Aortic stenosis is primarily a disease of the
geriatric population, especially disease severe enough to re-
quire valve replacement. Transcatheter aortic valve replace-
ment (TAVR) is the intervention of choice in patients with
severe AS who may not tolerate a more invasive surgical
intervention—and has included high proportions of older pa-
tients who are often regarded as too sick for CR by their
providers or families.
The evidence for exercise-based rehabilitation after valve
repair is quite limited, with a recent Cochrane review only able
to include two small trials [10] that showed benefits from
exercise capacity, but called for further trials to establish other
benefits. After TAVR, there are a few observational studies
that show benefits in functional status and quality of life [11,
12]. A recent small pilot study of 30 patients after TAVR by
Pressler et al. showed benefits in exercise capacity, strength,
and quality of life [13]. Of note, the studies of CR in TAVR all
had a mean age above 80 years, so while there is limited
evidence of the benefits in this population, the studies have
focused on older adults.
Peripheral Arterial Disease
Peripheral arterial disease (PAD) has seen a recent rise in
prevalence, with the majority of this growth in geriatric pa-
tients. It can be considered a disease of aging and contributes
substantially to the disability and impairment in physical func-
tion. Supervised exercise therapy (SET) was just recently ap-
proved for Medicare reimbursement as an intervention for
symptomatic (PAD) [14]. While exercise is only a single part
of a more comprehensive CR program, it still plays a poten-
tially decisive role in increasing CR referral and utilization.
This decision was based on evidence that SET has benefits in
quality of life and symptoms of claudication [15]. A recent
Cochrane review highlighted increased walking distance and
walking time, with some studies showing improvements in
patient-reported quality of life, though no effects on mortality,
cardiac events, or ankle-brachial index were reported [16].
While no studies of more comprehensive CR programs in
PAD have been published, there is a current trial underway
(NCT03251391).
 5 Page 2 of 6 Curr Cardiovasc Risk Rep  (2018) 12:5 
Age-Specific Benefits
The rationale that led to CR’s widespread use as secondary
prevention for AMI and after revascularization primarily fo-
cused on easily measured and broadly applicable outcomes
such as mortality and readmission. These benefits have been
difficult to demonstrate clearly in CHD and HF, but have not
been shown in valvular disease or PAD. While these types of
outcomes are extremely compelling, in older adults a broader
definition of benefit provides a more nuanced view of the
effects of CR. As the indications for CR have expanded, so
too has the field’s acknowledgement of broader CR benefits.
Functional capacity has become an important metric for CR’s
efficacy and has been an important determinant of the expan-
sion of CR use to HF, TAVR, and PAD.
Functional capacity is an especially important criterion for
older adults, and it is one of a few ways in which CR may
benefit older adults differently than their younger counter-
parts. Geriatric impairments in cognition or mobility can have
large effects on quality of life, and any effect of CR on these
impairments would be extremely meaningful. These potential
benefits can be lost in studies of CR that include younger
patients, and so research on CR on older adults is essential
to understanding how it can best be utilized in this population.
Functional Capacity
One of the key outcome measures of CR in all age groups is
physical function and exercise capacity. This bears particular
relevance to older adults because of the typical decline in
functional capacity associated with aging, the progressive na-
ture of disability in older adults, and the acute impact to func-
tion and exercise capacity of CVD and hospitalization. As part
of the normal process of aging, individuals will experience
changes on a cellular, muscular, and physiologic level that
can impair exercise or functional capacity. Even absent car-
diovascular disease, older adults experience a decline in peak
oxygen uptake (VO2 peak) with every decade, and this decline
accelerates in older age [17]. Muscle mass decreases with
aging as well [18], and there are numerous cellular and mo-
lecular changes associated with aging that diminish ability to
deliver oxygen (O2) to tissues as well as its utilization [19].
These changes are evenmore pronounced in the population
that is eligible for CR. Deconditioning is a known complica-
tion of hospitalization in the geriatric population [20]. In a
small 2014 study, DiMaria-Ghalili et al. demonstrated that
after cardiac surgery, older adults experience continued weight
loss in the context of elevated inflammatory markers. The
transient deconditioning and general period of increased risk
after hospitalization has become known as “post-hospitaliza-
tion syndrome [21],” pointing to how important interventions
to improve functional capacity after hospitalization can be in
this population.
In both CHD and HF, CR has been demonstrated to
increase functional capacity or its markers in older adults.
Studies of patients with ischemic heart disease showed that
effects on exercise capacity were just as great in older
adults as in younger patients [22, 23]. A recent observa-
tional study by Baldasseroni et al. found that those older
adults with the worst baseline function after AMI or surgi-
cal revascularization showed the most improvement of
physical performance associated with CR [24•]. Similarly
in HF, older adults had gains in functional capacity similar
to younger adults [25]. A recent study by Pandey et al.
contextualized this finding and showed that older adults
with HFpEF showed more improvement in exercise capac-
ity than those with HFrEF, despite the current policy ex-
cluding HFpEF from reimbursement for CR [26].
Frailty
Physical frailty is a key concept in the field of geriatrics. It can
be defined in multiple ways, but is essentially an indicator of
overall weakening and increased fatigability [27]. Frailty is a
known prognostic factor for many outcomes in geriatric pa-
tients. Recent studies have started to look at frailty as a possi-
bly therapeutic target. A meta-analysis by Bibas et al. found
13 randomized controlled trials investigating exercise training
on measures of frailty, and found that in most studies (12/13),
exercise training improved one or more markers of frailty,
although many of these studies did not specifically look at
patients with cardiovascular disease [28].
While exercise may help diminish frailty, it is possible that
such benefit could be compounded by specifically tailoring
the exercise regimen for older adults. A study by Molino-
Lova et al. specifically investigated older adults exhibiting
frailty after participating in acute rehabilitation following car-
diac surgery. They found a significant improvement in the
Short Physical Performance Battery with a structured physical
activity intervention focused on strength, flexibility, balance,
and coordination, and posit such an intervention could delay
or prevent the onset of disability.
Cognition [29, 30]
Cognitive impairment in older adults has been associated pre-
viously with CVD [30]. There is increasing evidence that CR
improves cognition in older adults. In patients with both HF
[29] and other forms of CVD, participation in exercise therapy
has been shown to increase cognitive functioning in multiple
domains [31, 32].
The molecular and physiologic mechanisms underpinning
the link between cognition and CVD are not fully explained as
of yet, but recent studies have suggested possible causal links,
including white matter changes [33] or alterations in perfusion
[31] which may be altered by CR. Furthermore, CR provides
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opportunity to modify medical regimens, potentially
deprescribing drugs that may inadvertently contribute to risks
of confusion as well as greater fatigability [34].
Mood
In those older adults with CVD, there is increased risk of
depression, and, through behavioral factors, depression can
be associated with adverse cardiovascular events [35].
Decreased functional capacity and ability to exercise is
thought to be a mediator of increased depression, and so work-
ing to alleviate this limitation has been a target to improve
mood symptoms in this population. A 2012 meta-analysis
on the effect of CR on depression showed that both
community-based and in-home CR caused significant im-
provement in depression outcomes in older adults [36]. Part
of the positive impact on patients’ mood symptoms may be
connected to the social aspect of CR. In a survey of adults
participating in CR, many highlighted socialization as a key
benefit [37].
Risks Associated with Cardiac Rehabilitation
in Geriatric Patients
CV Events
An early concern in CR was that initiating exercise too soon
after a cardiac event could cause another ischemic injury. As
CR has been studied, it has become clear that this is not the
case, and that the exercise performed as part of structured CR
programs is safe, with an exceedingly small risk of cardiac
events. The incidence of a coronary event, cardiac death, or
AMI has been estimated to be 1 every 60–80,000 patient
hours of supervised exercise. Whether this risk is different in
older patients participating in CR has not been specifically
studied, but the expert consensus is that CR is safe for all
eligible patients, and that no special considerations should
be taken for geriatric patients from this perspective.
Falls
One of the major concerns with initiating CR in the geriatric
population is that increased exercise could expose these pa-
tients to an increased risk of injurious falls. Unintentional falls
in older adults cause significant morbidity, increased
healthcare utilization, and mortality. The base rate of falls in
adults over 65 is roughly 30% per year [38], and those patients
eligible for CR may be at an even higher risk. These patients
could experience deconditioning while in the hospital, may
have increased likelihood of polypharmacy, and are more like-
ly to have cognitive impairment or frailty than other older
adults. The time after hospital discharge is a period of
increased fall risk [39], and so it is not surprising that pro-
viders are concerned about initiating exercise therapy in these
older adults.
Despite these concerns, there is a strong body of evidence
that CR can improve some of the risk factors for falls, such as
strength and balance [40]. Exercise training has been shown in
a systematic review and meta-analysis to be one of the most
effective interventions to prevent falls in older adults [41]. No
study has yet specifically investigated the rate of falls in CR
programs, and so it is important for programs to be aware of
this risk, and to modify exercises in ways that might minimize
the risk of falls in vulnerable older adults. Careful assessment
of hemodynamics and steps to adjust medications to mitigate
excessive hypotension and confusion also help to reduce fall-
ing risks [34].
Underuse
Despite the evidence of CR’s major benefits, rates of partici-
pation are remarkably low [42, 43•], particularly in candidates
who are older [44, 45]. This has led to calls from national
organizations, including the AHA, to increase rates of CR
utilization in older adults after AMI. Many factors have been
implicated in the underuse of CR, and older age has consis-
tently been shown to correlate with lower rates of utilization,
but few studies have investigated CR use in older adults.
Qualitative studies have identified barriers to participation
including transportation issues, patients’ unwillingness, and
financial constraints [46, 47]. Studies that have quantitatively
investigated factors associated with non-utilization have been
incorporated into a recent meta-analysis by Ruano-Ravina
et al. This study highlighted that older age is one of a number
of factors that predicts lower rates of utilization, including
female gender, lower educational attainment, lower income,
and comorbidities [43•]. One study of Medicare claims found
that among adults over 65, those eligible for CR who did not
participate were older, were more likely to be female, and had
more comorbidities than those who did participate [48].
While the patient characteristics that contribute to lower
referral rates in older patients are not clearly established, cli-
nicians’ actions have an impact. One such survey by Buttery
et al. found that older adults were just as likely to desire CR as
younger adults, but that they were much less likely to be
referred [49]. Lack of encouragement by a physician was spe-
cifically cited as a barrier to participation among older adults
in a qualitative study [50].
Special Considerations in Older Adults
Older adults have unique risks and benefits of CR participa-
tion, and they also have unique needs that require careful
consideration for CR implementation. Barriers to participation
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including lack of transportation, and cost, may be more diffi-
cult to overcome for older adults. Cognitive or sensory impair-
ments may require modification of the CR protocols. As many
older adults are discharged to skilled nursing facilities there
may be a role for incorporating elements of CR into care at
these facilities [51].
Home vs. Facility CR
Amore recent trend in CR has been the advent of home-based
programs for delivery. Given the unique needs of the geriatric
population, this could be a boon to increasing CR utilization
among older adults, and is part of the AHA recommendations
to increase CR referral [52], but careful review of the evidence
around these types of programs is important. The most recent
Cochrane review on home-based vs. facility-based CR ana-
lyzed 17 trials including 2172 patients with AMI, revascular-
ization, or HF and found that there was no difference in out-
comes between the two modes of delivery. Importantly, this
review did not address the impact of older age on these find-
ings, nor did it comment on any differences in safety between
home- and facility-based CR. One small study did focus on
patients with CHD over the age of 65 years and found that
there was no difference in peak VO2 or 6-min walk test [53].
A recent study evaluated a smartphone-based delivery of
CR and found that it was effective in increasing CR utilization
and improving health outcomes, but importantly it was a small
study with a mean age of 55, and it is reasonable to worry that
these results may not translate to an older cohort less comfort-
ably with such technology [54].
Conclusions
CR is clearly here to stay as an important tool in the car-
diologist’s armamentarium. As the population ages, and
the number of older adults eligible for CR grows, a nu-
anced understanding of the risks, benefits, and indications
for CR that are unique to the geriatric population will be an
essential aspect of care. The belief that CR has a mortality
benefit, especially in the geriatric population, is based pri-
marily on propensity analyses and meta-analyses rather
than straightforward RCTs. This is a relatively weak foun-
dation, but the supporting rationale can be buttressed by
future work on the functional and geriatric-specific bene-
fits of CR in older adults. These benefits in cognition,
frailty, and especially functional status are difficult to re-
search, and a keen geriatric lens must be applied.
Considerations of frailty and disability must account for
both the acute post-hospitalization decline in function and
the individual’s baseline capabilities. Those who undergo
invasive cardiac procedures may be more disabled in the
short term, but may have a higher level of baseline func-
tion, and may in fact be the patients who can benefit most
from an intervention like CR.
More study is clearly necessary in this field and can shine a
clearer light on the ways in which aging impacts CR.
Questions remain about the interplay between multimorbidity
and CR. More research can clarify how the calculus about
home vs. facility CR is affected by geriatric impairments that
may make delivery more complex. What interventions can be
taken to promote more use among older adults, who are uti-
lizing CR at a lower rate than their younger counterparts de-
spite their unique benefits? While questions remain, it is clear
that CR is an important tool for secondary prevention and
improvement of physical function for older adults with CVD.
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A risk model for falls in older patients after hospitalization for 
acute myocardial infarction: the SILVER-AMI study
D. W. Goldstein, T. Murphy, S. Tsang, A. M. Hajduk, M. Geda, 
M. Tinetti, S. I. Chaudhry. Internal Medicine, Yale School of 
Medicine, New Haven, CT.
Background: Discharge after hospitalization for acute myocar-
dial infarction (AMI) is typically marked by functional decline and 
other changes that modify the risk for falls. Prior research on falls 
has focused on hospitalized, community dwelling, and institutional-
ized populations, but the post-discharge period has been understud-
ied, especially after AMI. This study uses the expansive demographic, 
clinical, geriatric, and psychosocial data of the “ComprehenSIVe 
Evaluation of Risk Factors in Older Patients with AMI “ (SILVER-
AMI) cohort to build a risk model for falls in the 6 months after hospi-
talization for AMI.
Methods: SILVER-AMI is a prospective, multi-center longitu-
dinal cohort study of 3000 adults age 75 years or older hospitalized 
for AMI. Detailed baseline assessments and medical record abstrac-
tions were performed to collect demographic, clinical, geriatric, and 
psychosocial data. Falls were self-reported in a telephone interview 
six months after discharge, and analysis was performed on the first 
1700 patients enrolled. After multiple imputation for missing data, 
85 hypothesized predictors were narrowed to 26 using backward 
selection. Bayesian model averaging was applied to the combination 
of these 26 variables and four established predictors (age, gender, race, 
prior falls) to develop a final risk model for falls.
Results: 23% of patients reported ≥1 fall at 6 months post- 
discharge. Our model identified the following fall risk factors: prior 
falls [OR 2.35 (95%CI 1.85-2.98)], cognitive impairment [OR 1.42 
(1.03-1.96)], slow gait [OR 1.13 (1.00-1.28)], and visual impairment 
[OR 1.46 (1.15-1.86)]. Living with a partner [OR 0.67 (0.53-0.85)] 
and non-white race [OR 0.59 (0.38-0.93)] were shown to be protec-
tive. Traditional cardiovascular risk factors for post-AMI outcomes, 
such as blood pressure and renal function, were not predictive.
Conclusions: This risk model allows the identification of adults 
over 75 at increased risk for falls following hospital discharge after 
AMI. This risk stratification could inform clinical decisions at the 
time of hospital discharge and increase use of preventive interventions 
such as exercise programs or home hazard reduction. In older patients, 
geriatric impairments were strongly predictive of falls but traditional 
cardiovascular risk factors for post-AMI outcomes were not.
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Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and 
Sulfonylureas in Older Nursing Home Residents
A. R. Zullo,1 R. Gutman,1 R. J. Smith,1 V. Mor,1 D. D. Dore.1,2 
1. Brown University, Providence, RI; 2. Optum Epidemiology, 
Boston, MA.
Background: The comparative safety profiles of dipeptidyl 
peptidase-4 inhibitors (DPP4Is) and sulfonylureas (SUs) have not 
been studied for older nursing home (NH) residents with type 2 diabe-
tes. We evaluated the risk of major adverse cardiovascular events 
(MACE), glycemic events, and all-cause mortality in NH residents 
aged !65 who were newly prescribed DPP4Is versus SUs.
Methods: We conducted a retrospective cohort study of 7,885 
U.S. NH residents using 2007-2010 national data from the Minimum 
Data Set and Medicare Parts A, B, and D. Follow-up began at the 
initial dispensing of a DPP4I or SU and continued until each study 
outcome (evaluated separately), insurance disenrollment, death (for 
non-death outcomes), one-year follow-up, or study end, which ever 
occurred first. Outcomes were hospitalizations and emergency depart-
ment visits for heart failure (HF), acute myocardial infarction (AMI), 
stroke, hypoglycemia, hyperglycemia, and death. We propensity 
score-matched new DPP4I users to an equal number of SU users. Cox 
models were used to determine hazard ratios (HR) with 95% CIs of 
each outcome. We used competing risk regressions and nonparametric 
propensity scores in sensitivity analyses.
Results: Propensity score-matching yielded a cohort of 2,016 
residents. Mean age was 81 years. DPP4I users were less likely than 
SU users to experience hypoglycemia (HR=0.57, 95%CI 0.34-0.95) 
and stroke (HR=0.27, 95%CI 0.12-0.59), but had a similar risk of HF, 
AMI, hyperglycemia, and death (Figure). Results from the sensitivity 
analyses were similar.
Conclusions: NH residents who initiated DPP4Is instead of 
SUs had a lower risk of hypoglycemia and stroke. Since avoidance of 
hypoglycemia is a key diabetes treatment goal in the NH, our findings 
suggest that DPP4Is are the preferred therapy.
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Chronic Pain Predicts Accelerated Memory Decline and 
Dementia in a Longitudinal Cohort of Elders
E. L. Whitlock,1 L. G. Diaz-Ramirez,2 M. M. Glymour,3 
J. Boscardin,2,3 K. E. Covinsky,2 A. K. Smith.2 1. Anesthesiology  
& Perioperative Care, University of California, San Francisco, 
San Francisco, CA; 2. Division of Geriatrics, Department of 
Medicine, University of California, San Francisco, San Francisco, 
CA; 3. Epidemiology & Biostatistics, University of California, San 
Francisco, San Francisco, CA.
Background: Chronic pain is highly prevalent among the elderly 
and is associated with cognitive deficits in cross sectional studies. 
Using data from the Health and Retirement Study (HRS), we modeled 
the association between chronic pain at cohort inception and longitudi-
nal measures of memory and dementia probability over the following 
12 years.
Methods: We studied 10,065 HRS participants who were at least 
62 in 2000 and answered pain and cognition questions by self-report 
in both 1998 and 2000. “Chronic pain” was defined as a participant 
reporting he/she was often troubled with moderate or severe pain in 
both the 1998 and 2000 HRS interviews. Composite memory score 
and dementia probability estimated by combining neuropsychological 
tests and informant interviews were tracked until the 2012 interview. 
Demographic and comorbidity covariates were fixed at the 2000 inter-
view. Linear mixed effects models, with random slope and intercept 
for each participant, were used to estimate the impact of chronic pain 
on slope of the memory score and dementia probability trajectory, 
applying sampling weights to represent the 2000 US population age 
62+. To contextualize the magnitude of associations, we estimated 
the impact of memory differences associated with pain on functional 
independence in managing medications and finances.
Results: Chronic pain affected 10.9% of the weighted cohort. 
After adjustment for health and demographic factors, chronic pain 
was associated with 9.2% (95% CI 2.8%-15.0%) more rapid memory 
decline compared with controls. This memory score decrement trans-
lated to a 15.9% relative higher risk of inability to manage medica-
tions and 11.8% relative higher risk of inability to manage finances 
independently at the end of 10 years, compared with peers. Dementia 
